Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 is a research paper published in Science (2021). On theSindex it has a DataRank of 0. It has been cited 223 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P50AI150476
National Institutes of Health
Grant: U19AI135990
National Institutes of Health
Grant: U19AI135972
National Institutes of Health
Grant: R01AI143292
National Institutes of Health
Grant: R01AI120694
National Institutes of Health
Grant: P01AI063302
National Institute of General Medical Sciences
Grant: R35GM122481
Defense Advanced Research Projects Agency
Grant: HR0011-19-2-0020
National Institute of General Medical Sciences
Grant: R01GM119185
National Institutes of Health
Grant: R01AI122747
National Institute of Allergy and Infectious Diseases
Grant: HHSN272201400008C
National Institute of Allergy and Infectious Diseases
Grant: W81XWH-20-1-0270
ASCRS Research Foundation
Grant: DRG-2281-17
George Mason University
Grant: COVID-19 F
National Institutes of Health
Grant: NIGMS R35GM122481
GlaxoSmithKline foundation
Grant: COVID-19
Open Philanthropy Project
Grant: 2020-215611
Labex IBEID
Grant: ANR-10-LABX-62-IBEID
NIGMS NIH HHS
Grant: T32 GM142516
NIGMS NIH HHS
Grant: T32 GM007175
Damon Runyon Cancer Research Foundation
Howard Hughes Medical Institute
MeSH Terms